Literature DB >> 9510130

Thyrotropin receptor expression in cultured Graves' orbital preadipocyte fibroblasts is stimulated by thyrotropin.

R S Bahn1, C M Dutton, W Joba, A E Heufelder.   

Abstract

Our laboratory has shown recently that the thyrotropin receptor (TSHr) is expressed in orbital adipose/connective tissues from patients with Graves' ophthalmopathy (GO), and that this receptor is not demonstrable in orbital tissues from normal individuals. In order to study the regulation of TSHr expression in the orbit in GO, we treated cultures of Graves' orbital preadipocyte fibroblasts with the TSHr ligand thyrotropin (TSH; 100 mU/L). We found increased expression of both intact (2.4 kb) and variant (1.3 kb) TSHr mRNA and of TSHr protein in orbital fibroblasts following 72 hr treatment with TSH. These studies suggest that the expression of this receptor in the orbit in vivo may be stimulated by TSH or other TSHr ligands, and that this stimulation may be important in the development of GO.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9510130     DOI: 10.1089/thy.1998.8.193

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  9 in total

1.  The role of thyroid eye disease and other factors in the overcorrection of hypotropia following unilateral adjustable suture recession of the inferior rectus (an American Ophthalmological Society thesis).

Authors:  Natalie C Kerr
Journal:  Trans Am Ophthalmol Soc       Date:  2011-12

Review 2.  Immunohistochemical analysis of human orbital tissue in Graves' orbitopathy.

Authors:  Y P Hai; A C H Lee; L Frommer; T Diana; G J Kahaly
Journal:  J Endocrinol Invest       Date:  2019-09-19       Impact factor: 4.256

Review 3.  Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptor.

Authors:  Seethalakshmi Iyer; Rebecca Bahn
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2012-06       Impact factor: 4.690

4.  Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.

Authors:  Chu Zhang; Xianfeng Zhang; Lizhen Ma; Fengying Peng; Jiao Huang; Hui Han
Journal:  Endocrine       Date:  2012-01-12       Impact factor: 3.633

Review 5.  Pathogenesis of ophthalmopathy in autoimmune thyroid disease.

Authors:  A E Heufelder
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

6.  Impaired immune regulation after radioiodine therapy for Graves' disease and the protective effect of Methimazole.

Authors:  Sarah Côté-Bigras; Viet Tran; Sylvie Turcotte; Marek Rola-Pleszczynski; Jean Verreault; Diane Rottembourg
Journal:  Endocrine       Date:  2015-12-23       Impact factor: 3.633

7.  TSH stimulates adipogenesis in mouse embryonic stem cells.

Authors:  Min Lu; Reigh-Yi Lin
Journal:  J Endocrinol       Date:  2008-01       Impact factor: 4.286

8.  Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy.

Authors:  Diego Strianese; Francesca Rossi
Journal:  Eye (Lond)       Date:  2019-01-04       Impact factor: 3.775

9.  TSHR Signaling Stimulates Proliferation Through PI3K/Akt and Induction of miR-146a and miR-155 in Thyroid Eye Disease Orbital Fibroblasts.

Authors:  Collynn F Woeller; Elisa Roztocil; Christine Hammond; Steven E Feldon
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-10-01       Impact factor: 4.799

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.